Latham & Watkins has advised Arcus Biosciences. Gunderson Dettmer has advised the underwriters. Arcus Biosciences, a clinical-stage, global biopharmaceutical company listed on the NYSE under the...
You must be a Standard 1 Year member to access this content.
WilmerHale has advised Thermo Fisher Scientific. Latham & Watkins has advised Clario and a consortium led by Astorg, Nordic Capital, Novo Holdings, and Cinven. Thermo Fisher...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP has advised Neuberger Berman Capital Solutions. Weil, Gotshal & Manges LLP has advised OMERS Private Equity and Paradigm. Neuberger Berman Capital Solutions...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Boston Scientific, while K&L Gates advised SoniVie Ltd. on the transaction. Boston Scientific Corporation (NYSE: BSX) announced it has entered into a...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz, Kirkland & Ellis, and Orrick, Herrington & Sutcliffe are serving as legal advisors to Carlyle and SK Capital, while Latham &...
You must be a Standard 1 Year member to access this content.
Wyrick Robbins Yates & Ponton served as legal advisor to Globus Medical, Inc., while Latham & Watkins served as legal advisor to Nevro Corp. Fried Frank...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented OMERS Life Sciences in the transaction, while Latham & Watkins advised Verona Pharma and Sullivan & Cromwell represented Oaktree Capital Management, L.P. Verona...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Harmony Biosciences, while Paul Hastings LLP advised J.P. Morgan as the sole book-running manager in the offering. Harmony Biosciences Holdings, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Goodwin Procter, McDermott Will & Emery, and Mason Hayes & Curran advised LetsGetChecked, while Latham & Watkins and BakerHostetler advised Truepill on the deal. LetsGetChecked, a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Seres Therapeutics, while Mayer Brown represented Société des Produits Nestlé on the deal. Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised scPharmaceuticals on the deal. scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
You must be a Standard 1 Year member to access this content.
Cravath, Swaine & Moore represented Illumina, Inc. on the transaction, and Latham & Watkins represented GRAIL, LLC. GRAIL, Inc. (NASDAQ: GRAL, formerly GRAIL, LLC), a healthcare...
You must be a Standard 1 Year member to access this content.
